The main purpose of this study is to evaluate the effectiveness of a new treatment in improving chronic migraine symptoms. This treatment involves a targeted lidocaine infusion into blood vessels in the skull to numb pain receptors, potentially leading to improvements in chronic migraine intensity, frequency, and duration.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-01; most recent amendment 2026-05-19.